News
President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...
Rite Aid has sold the pharmacy services of most of its stores across the United States to several rivals. The bankrupt ...
The insolvent genetic analysis company 23andme is taken over by a pharmaceutical company that wants to continue the business ...
President Trump's executive order aims to slash prescription drug prices by up to 80% by targeting pharmacy benefit managers, ...
Houston-based Empower Pharmacy has rapidly expanded over the past decade. Now a competitor is suing Empower, alleging its ...
Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.
Sanofi SA said it will invest at least $20 billion in the US through 2030, joining other European pharmaceutical companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results